Skip to content

MEDIKAN

Active
Private limited companyfounded 20214 yrs activePaul Jansonlaan 66, 1070 Anderlecht, BelgiumKBO/BCE: BE 0778.279.795

The computed 12-month bankruptcy probability of MEDIKAN is 5.9% (elevated). The 2025 annual accounts show equity of €50k and a net result of €24k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
81 / 100
Excellent▲ +36 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency49▲+29
Growth52▲+20
Stability94
Bankruptcy probability, 12 months
5.9% Elevated
0%0.5%1.5%4%10%≥ 25%
Credit up to €4k at 30 days acceptable
Liquidity ample (current ratio 1.61 against 0.9 in 2024), but 75.9% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Eight signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 4 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
24.1%
Return on assets
11.5%
Age of the figures
8 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-08-2026, 12 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 5 filings
Deviation from the deadline
2025
12 d late
2024
25 d late
2023
41 d late
2022
58 d late
2021
26 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
14-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€50k▲ 92.2%
2024 · €26k
2021: €48k 2022: €87k 2023: €146k 2024: €26k
2021 → 2025
Total assets
€207k▲ 25.9%
2024 · €165k
2021: €61k 2022: €130k 2023: €163k 2024: €165k
2021 → 2025
Net result
€24k▲ 22.9%
2024 · €19k
2021: €45k 2022: €39k 2023: €60k 2024: €19k
2021 → 2025
Working capital
€60k
2024 · €-10k
2021: €26k 2022: €62k 2023: €49k 2024: €-10k
2021 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€48k-€87k▲ 80.0%€146k▲ 68.6%€26k▼ 82.3%€50k▲ 92.2%
Operating result€56k-€48k▼ 15.1%€75k▲ 57.3%€25k▼ 66.0%€35k▲ 36.9%
Net result€45k-€39k▼ 12.6%€60k▲ 53.2%€19k▼ 67.7%€24k▲ 22.9%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40k€60k€80kOperating result 2021: €56k€56kNet result 2021: €45k€45kOperating result 2022: €48k€48kNet result 2022: €39k€39kOperating result 2023: €75k€75kNet result 2023: €60k€60kOperating result 2024: €25k€25kNet result 2024: €19k€19kOperating result 2025: €35k€35kNet result 2025: €24k€24k20212022202320242025
The operating result recovers in 2025; 2025 is 37% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €207k
Fixed assets €49k▼ 31.5%
Current assets €158k▲ 70.5%
Equity and liabilities €207k
Equity €50k▲ 92.2%
Debt €157k▲ 13.5%
The debt ratio falls from 84.2% to 75.9%: equity grows faster than debt.
Key figures and ratios
2025 value · change against 2024
EBITDA
€59k
2024 · €51k
Cash flow
€49k
2024 · €45k
Solvency
24.1%
2024 · 15.8%
Current ratio
1.61
2024 · 0.90
Quick ratio
1.61
2024 · 0.90
Debt / equity
3.15
2024 · 5.34
ROE
48.0%
2024 · 75.0%
ROA
11.5%
2024 · 11.8%
Interest coverage
29.91
2024 · 77.51
Debt
€157k
2024 · €139k
Debt ≤ 1 year
€98k
2024 · €103k
Income taxes
€9k
2024 · €5k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€165k€207k
Fixed assets21/28€72k€49k
Tangible fixed assets22/27€72k€49k
Plant, machinery and equipment23€902€697
Furniture and vehicles24€71k€49k
Current assets29/58€93k€158k
Amounts receivable within one year40/41€7k€11k
Trade receivables40€2k€0
Other amounts receivable41€5k€11k
Cash at bank and in hand54/58€83k€139k
Deferred charges and accrued income490/1€3k€8k
Equity and liabilities
Total equity and liabilities10/49€165k€207k
Equity10/15€26k€50k
Contributions10/11€4k€4k=
Profit (loss) carried forward14€22k€46k
Amounts payable17/49€139k€157k
Amounts payable within one year42/48€103k€98k
Trade debts44-€6k
Suppliers440/4-€6k
Taxes, remuneration and social security45€15k€0
Taxes450/3€15k€0
Other amounts payable47/48€88k€92k
Accrued charges and deferred income492/3€36k€60k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€25k€25k
Other operating charges640/8€70€1k
Gross operating margin9900€51k€61k
Operating profit (loss)9901€25k€35k
Financial income75/76B-€18
Recurring financial income75-€18
Financial charges65/66B€652€2k
Recurring financial charges65€652€2k
Profit (loss) for the period before taxes9903€25k€33k
Income taxes67/77€5k€9k
Profit (loss) for the period9904€19k€24k
Profit (loss) for the period to be appropriated9905€19k€24k
Appropriation of the result
Profit (loss) to be appropriated9906€162k€46k
Profit (loss) brought forward from the previous period14P€142k€22k
Profit to be distributed694/7€140k€0
Return on contributions (dividend)694€140k€0

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
12-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 12 days late
2025
25-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 25 days late
2024
31-12
Financial Weakest financial yearnet €19k ▼67.7%
Net result drops to €19k, the lowest in the series; recovery starts the following year.
10-09
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 41 days late
2023
31-12
Financial Highest result since 2021net €60k ▲53.2%
Operating result €75k, net result €60k, both a record.
31-12
Financial Equity above €100kEq €146k ▲68.6%
3 profitable years in a row build equity to €146k.
27-09
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 58 days late
2022
26-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 2 establishment units since 2021
establishment All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Paul Jansonlaan 661070 Anderlecht
Ground area
431 m²
Building footprint
291 m²
Volume, LiDAR
2,648 m³
2 parcels, Brussels · tallest building 18.7 m, ±4 floors. Linked by address, not a title deed.
2 establishment units
MEDIKAN
Paul Jansonlaan 66, 1070 AnderlechtGeneral medical practice
since 20212.324.902.136
Liverpoolstraat 37, 1080 Sint-Jans-Molenbeek
General medical practice
since 20252.375.143.087
2 parcels
Brussels 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21308H0508/00X005 Brussels 310 m² 1 · 89 m² 16.8 m · 4 fl.
21523B0945/00P005 Brussels 120 m² 1 · 203 m² 18.7 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded06-12-2021
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 5 filingsAddress and cadastre registers

Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.